Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Status:
Recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
Study of Chidamide Combined With Immunotherapy in Patients With Locally Advanced or
Metastatic Urothelial Carcinoma Who Had Previously Received Platinum-based Chemotherapy